Sensei Biotherapeutics, Inc.
4 clinical trials · Sponsor
◉ Watch Sensei Biotherapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors (NCT05864144) | Sensei Biotherapeutics, Inc. | 2023-05-31 |
| SNS-301 Monotherapy in High Risk MDS and CMML (NCT04217720) | Sensei Biotherapeutics, Inc. | 2020-04-01 |
| Addition of SNS-301 to Checkpoint Inhibitor Treatment in Metastatic/Recurrent SCCHN (NCT04034225) | Sensei Biotherapeutics, Inc. | 2019-11-11 |
| Phase 1 Trial of PAN-301-1 (SNS-301) in Cancer Patients (NCT03120832) | Sensei Biotherapeutics, Inc. | 2016-12-01 |
Track Sensei Biotherapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.